DHR
DANAHER CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$234.38
+1.86%Leverage
- Debt / equity
- 0.49x
- Net debt / equity
- 0.39x
- Debt / assets
- 0.28x
- Debt / EBITDA
- 3.74x
- Net debt / EBITDA
- 2.93x
Liquidity & coverage
- Current ratio
- 1.63x
- Quick ratio
- 1.29x
- Cash ratio
- 0.63x
- Interest coverage
- 35.74x
- EBITDA / interest
- 48.54x
- Working capital
- $5.7B
Cash & dividend
- FCF / debt
- 0.22x
- Cash flow / debt
- 0.26x
- Dividend per share
- $1.52
- Dividend yield
- 0.6%
- Dividend growth 1y
- +18.5%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026